$AKAM

Anthropic Signs $11.6 Billion Cloud Contract With Akamai, Gains Path to Stock Stake

Anthropic signed a $11.6B, 7-year cloud contract with Akamai, with potential for an additional $9B. Akamai will provide AI infrastructure and software, and issued Anthropic a warrant for up to 5% of its stock. Akamai expects $5.5B in capital expenditures, with no impact on 2026 revenue guidance. Shares surged in after-hours trading.

Original reporting
Published Sep 25, 2026, 8:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Anthropic Signs $11.6 Billion Cloud Contract With Akamai, Gains Path to Stock Stake — source image
Decision brief

The 30-second read

$AKAMBullishHigh
01

Why it matters

The deal secures a high‑value AI customer and introduces a potential equity upside via warrants.

02

Market read

A major AI‑related cloud contract that could boost Akamai's revenue and stock price.

03

What to watch

Capital‑expenditure required to deliver the service may pressure margins in 2026.

Relevance 9/10Novelty 9/10Timing: after‑hours reaction

Background

Akamai is a leading content delivery and edge computing provider; Anthropic is a private AI startup.

Company-level read

Ticker impact

$AKAMBullishHigh confidence
Context

Akamai announced an $11.6 billion 7‑year cloud contract with Anthropic, causing after‑hours share surge.

Expected impact

Expect continued buying pressure in pre‑market trading as investors price in higher 2026 revenue and cap‑ex.

Evidence & confidence

Large, newly disclosed contract with a strategic AI customer and a warrant issuance creates both revenue and equity upside.

Market effects

Strengthens demand for edge/cloud infrastructure in the AI sector.

Highlights U.S. cloud providers' role in supporting AI workloads.

Signals growing AI infrastructure spending worldwide.

Counterpoint

If Anthropic reduces spend or switches providers, Akamai's projected upside could be overstated.

Key entities

  • Akamai Technologies

    US‑listed provider of cloud and edge services (ticker AKAM).

  • Anthropic

    Private AI startup partnering with Akamai for cloud infrastructure.

Related articles

$AKAMHighAI 9/10

Anthropic to pay Akamai $11.6 billion over seven years in cloud deal

Anthropic will spend $11.6B over seven years on Akamai's cloud infrastructure, according to Akamai. The deal, contingent on meeting service requirements, is the largest in Akamai's history. Akamai expects $150M-$300M in 2027, growing to $1.7B annually by late 2028. Akamai will invest $5.5B to expand capacity and issued Anthropic a warrant for up to 5% of its stock.

$AKAMHighAI 9/10

Akamai signs $11.6 billion computing supply deal with Anthropic

Akamai Technologies signed a $11.6 billion deal to provide computing capacity to Anthropic over seven years. Shares rose over 20% in after-hours trading. Anthropic may add $9 billion, expanding the deal to $20 billion, and has an option to acquire up to 5% of Akamai's shares. Akamai's CEO cited its large-scale AI infrastructure capabilities as the reason for the partnership.

$AKAMMedAI 8/10

Akamai’s 11.6 billion dollar Anthropic deal ties cloud revenue to a 5.5 billion dollar buildout

Akamai has signed a 7-year deal with Anthropic for $11.6B in cloud services, potentially expanding to $20B. The deal requires $5.5B in upfront capital spending. Revenue recognition is expected from 2027, with a run rate of $1.7B/year. Akamai issued a warrant for up to 5% of its stock, vesting based on expansion. The deal does not change 2026 revenue guidance.

$BPMed

Wall Street analyst calls for the week of Sep 21–25, 2026

Wall Street analysts highlighted energy, AI infrastructure, and agriculture as key themes. BP (BP) and Chevron (CVX) were upgraded, while TotalEnergies (TTE) saw mixed views. Marathon Petroleum and Akamai (AKAM) were noted for AI infrastructure. Deere & Company (DE) rose on crop price expectations. Moderna (MRNA) faced polarizing views ahead of trial results.